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 ABSTRACT 
High quality up-to-date systematic reviews are essential in order to help healthcare practitioners and 
researchers keep up-to-date with a large and rapidly growing body of evidence.  Systematic reviews 
answer pre-defined research questions using explicit, reproducible methods to identify, critically 
appraise and combine results of primary research studies.  Key stages in the production of 
systematic reviews include clarification of aims and methods in a protocol, finding relevant research, 
collecting data, assessing study quality, synthesising evidence, and interpreting findings.  Systematic 
reviews may address different types of questions, such as questions about effectiveness of 
interventions, diagnostic test accuracy, prognosis, prevalence or incidence of disease, accuracy of 
measurement instruments, or qualitative data. For all reviews it is important to define criteria such 
as the population, intervention, comparison and outcomes, and to identify potential risks of bias.  
Reviews of the effect of rehabilitation interventions or reviews of data from observational studies, 
diagnostic test accuracy, or qualitative data may be more methodologically challenging than reviews 
of effectiveness of drugs for the prevention or treatment of stroke. Challenges in reviews of stroke 
rehabilitation can include poor definition of complex interventions, use of outcome measures that 
haven’t been validated, and poor generalisabilty of results. There may also be challenges with bias 
because the effects are dependent on the persons delivering the intervention, and because masking 
of participants and investigators may not be possible.  There are a wide range of resources which 
can support the planning and completion of systematic reviews, and these should be considered 
when planning a systematic review relating to stroke.   
 
1. INTRODUCTION 
1.1 Why do a systematic review in stroke? 
In order to provide patients with the best possible care and treatment, healthcare decisions should 
be based on up-to-date, high quality research evidence (1, 2). However, there is an unmanageably 
large and continually growing body of research evidence, and healthcare practitioners do not have 
time to keep up to date with this evidence base (3, 4).  There has also been an exponential increase 
in the amount of stroke research over the last 50 years (see Figure 1).  In April 2017, the Cochrane 
Stroke Group trials register contained 24,084 references to 9,975 randomised or controlled clinical 
trials relating to stroke, and a search of any key electronic bibliographic database reveals that there 
are tens of thousands of non-randomised studies relating to stroke. Still, despite important advances 
in evidence-based stroke care (5, 6), stroke survivors still do not always get the best possible care 
(7). High quality up-to-date systematic reviews of primary research studies, addressing questions 
which are of recognised importance to stroke survivors, carers and clinicians are therefore essential 
(8, 9). Systematic reviews are also important for the avoidance of research waste, by ensuring that 
new primary research is done with full knowledge of what has already been done, and that new 
research evidence is interpreted in the light of what is already known (10-12). 
1.2 What is a systematic review? 
A systematic review aims to bring evidence together to answer a pre-defined research question. This 
involves the identification of all primary research relevant to the defined review question, the critical 
appraisal of this research, and the synthesis of the findings (13).  Systematic reviews may combine 
data from different research studies in order to produce a new integrated result or conclusion, or 
they may bring together different types of evidence in order to explore or explain meaning (14). 
Systematic reviews can address any defined research question.  Table 1 provides examples of 
questions that have been addressed in published reviews relating to stroke, and examples of 
resources relating to different types of reviews.  The table illustrates that there are different types 
and methods of systematic review for different types of questions.  This is the same as when 
selecting a method for primary research, where the type of research question influences selection of 
an appropriate method (e.g. a question about the effect of an intervention may be best answered by 
a randomised controlled trial, or a question about prognosis best answered by an observational 
cohort study).  A high quality systematic review will try to identify all primary research studies that 
are relevant, both published and unpublished, carried out all over the world and written in different 
languages.  The quality of the identified research will be critically appraised, and the results of 
studies will be systematically brought together in order to provide the best possible answer to the 
review question; this process may involve the statistical combination of study results (meta-analysis) 
or other approaches to data synthesis.   In this way a systematic review of evidence should support 
the delivery of optimal healthcare interventions and research. 
Essential features of systematic reviews include explicit, reproducible methods for identification of 
primary research studies and critical assessment and synthesis of studies that meet the eligibility 
criteria (3, 15-17).   Systematic reviews should be distinguished from “non–systematic” reviews 
which do not have these features, and which are sometimes also described as a “conventional 
literature review” (18), “scoping review” (19), or “narrative review” (20).  In the past there has been 
considerable confusion and inconsistency in the terminology used around systematic reviews (21), in 
part because historically the term “systematic review” had often been associated specifically with 
the bringing together of data from quantitative research studies.  However it is now widely 
recognised that a “systematic review” refers to the process of systematically bringing together the 
results of any research, including qualitative or mixed methods research studies (22, 23). 
There is growing recognition of the importance of patient and public involvement to the value and 
relevance of systematic reviews (24), and some key organisations now identify patient and public 
involvement as an essential feature of a systematic review (e.g.  (15)).   Patient and public 
involvement within systematic reviews is increasingly asked for by funders of health research 
(e.g.(25, 26), including stroke research (e.g.(27)).  
1.3 Systematic reviews in stroke 
Most systematic reviews in stroke are reviews of interventions for prevention, acute treatment and 
rehabilitation (28). While reviews of the effectiveness of drugs to prevent or treat stroke may 
arguably be relatively straight-forward, reviews of complex interventions, such as rehabilitation, are 
more complicated, as are reviews of diagnostic test accuracy or qualitative data. Challenges in 
reviews of stroke rehabilitation can include poor definition, implementation and description of 
complex rehabilitation interventions (29-32); inconsistent use of outcome measures, or use of 
outcome measures that haven’t been validated (33); or poor generalisabilty of results (for example, 
because of exclusion of participants with aphasia or cognitive impairment (34)).  Furthermore stroke 
rehabilitation research has particular challenges because the effects are dependent on the person 
delivering the intervention, and blinding of participants and staff to randomised interventions may 
not be possible within some studies.   
In this article our objective is to outline the systematic review process, from the planning of the 
review, through the writing of the protocol and the completion, publication and dissemination of the 
review (Figure 2).  We focus primarily on reviews of the effect of interventions for prevention, acute 
treatment and rehabilitation of stroke, but we also incorporate and discuss other types of systematic 
reviews, such as reviews of diagnostic accuracy and reviews of qualitative data. We use an example 
from stroke rehabilitation (35) to illustrate methodological challenges, since reviews of rehabilitation 
are often more methodologically complex than reviews of prevention and acute treatment.    
2. PLANNING A SYSTEMATIC REVIEW 
2.1. What is the research question? 
A systematic review should be prompted by an interest in a topic, and a wish to answer a specific 
question.  The question should clarify the problem to be addressed, specifying the particular 
population to which the question applies, as well as any intervention and outcomes of interest.  How 
to form a systematic review question is considered further below.  Box 1 illustrates how an initial 
interest in the effect of rehabilitation interventions was formulated into a research question. 
2.2. Is a systematic review needed? 
For any research to be justified, including systematic reviews, the research question must address 
what is important to patients and clinicians (11). If a research question is of low priority to the 
people affected by the condition, or important outcomes are not considered, or the intervention is 
considered unacceptable to patients, or too costly to deliver, then further research can be wasteful 
(10, 11).  There are a number of reports which highlight key topics and research questions which are 
considered of greatest importance by stroke survivors, carers and health professionals working in 
stroke care (36-41). 
In addition, if a research question has already been answered by a systematic review, another 
review of the same evidence will be wasteful and creates challenges for clinicians and policy makers 
seeking systematic reviews to inform their clinical decision making (42).  There are currently (March 
2017) at least 1385 systematic reviews relating to stroke (28).  An overview of reviews relating to 
stroke upper limb rehabilitation identified multiple overlapping reviews, with over 10 published 
systematic reviews of evidence relating to constraint-induced movement therapy  and electrical 
stimulation (42). 
It is sometimes argued that an additional criterion to consider is whether there is published research 
relevant to the research question.   A systematic review which does not find and include any 
relevant studies can be referred to as an “empty review” (43).  These empty reviews arguably are of 
little value in aiding clinical decisions, and subsequently careful consideration should be given to 
embarking on what may be an empty review.  However, where the intention is to complete a 
systematic review in order to confirm the absence of primary research, prior to the planning and 
conduct of a primary research study, there remains clear justification for a systematic review. 
2.3 Feasibility and scope of the systematic review 
It is estimated that a typical systematic review will take at least 12 months to complete, although 
this could be less, depending on the review and the available resources (44).  Data from the 
Cochrane Stroke Group demonstrates that completion time for a Cochrane systematic review, from 
initial registration of a title to publication of a completed review, is a median of 158 weeks 
(interquartile range 105 to 209). Although the scope of a systematic review will largely be 
determined by the research question which has been formulated, there may be opportunities to 
broaden or narrow a research question in an attempt to make the planned review manageable 
within the available time and resources (45).  A broader review question (sometimes known as a 
“lumping” review) has the advantage that it will be applicable to a wider range of settings or 
populations (or interventions or outcomes), and provides greater potential for exploration of 
consistency of research findings, with less opportunities for chance findings (46, 47).  Furthermore 
broad reviews arguably make systematic review findings more accessible to clinical decision makers, 
who often have to choose between a variety of interventions for delivery to a number of different 
patients.  However when resources are limited, a narrower review (or “splitting” a review) may 
make completion more feasible, and the increased homogeneity of the included studies may provide 
a more focused answer to the specific (narrow) research question (47). Box 2 gives arguments for a 
broad and for a narrow review, using the example of rehabilitation interventions.  
2.4 What sort of systematic review best suits the research question? 
The type of research question which has been asked will be central to determining the most 
appropriate type of systematic review (Table 1).  The research questions in Box 1 and Box 2 require 
an intervention review. 
3. WRITE AND PUBLISH A PROTOCOL 
A protocol is an essential part of the review process (17, 48-51), and should include sufficient 
information to enable independent replication of the methods. Adherence to a pre-defined protocol 
is a key method with which to avoid the introduction of selection bias, as it ensures that all 
important decisions have been made in advance of knowledge of the results (49-52). Peer review 
and feedback from key stakeholders is important (16, 17, 50), and a protocol should be published 
prior to starting on the systematic review, for example in a repository, electronic library (e.g. (53-55) 
or in a journal.   Publication helps ensure transparency within the review process, enabling any 
deviation from review protocol to be easily identified (50, 52, 56). For example, prior publication of a 
protocol will enable selective outcome reporting to be identified if this occurs within the final review 
(48, 49, 52).  Furthermore publication is a key step to avoid research duplication and waste, ensuring 
that other researchers are aware that the review is being completed (49, 50, 52). Figure 3 illustrates 
the key stages for writing a protocol and completing a systematic review.  Each stage is briefly 
discussed below, and key resources highlighted (Table 1). 
3.1. Clarify review aims and objectives 
A clear research question, like the one in Box 1, will help clarify the eligibility criteria for inclusion of 
relevant studies (and exclusion of irrelevant studies). For relatively simple systematic reviews of 
effectiveness of interventions, the systematic review question is often informed by the “PICO” 
framework, but there are a range of other frameworks which can inform the questions for more 
complex reviews (Table 1)(57).   
There are some specific considerations relating to systematic reviews in stroke. For example, when 
defining the population (P) it may be important to state how stroke is defined or diagnosed, or to 
define a specific subset of participants (e.g. participants with aphasia), or those within a specific care 
setting.  Sometimes it may be appropriate to broaden the scope of the review by including other 
relevant populations in addition to stroke (e.g. other non-progressive brain diseases/injuries).   
Defining interventions (I) used in stroke care, particularly non-pharmacological interventions, can be 
complex, and careful consideration should be given to describing the key components of the 
intervention.  The TIDieR checklist (58) may provide a useful guide to clarifying the intervention, and 
ensuring a structured definition.  Careful consideration should be given to the “dose” of complex 
interventions, clarifying how this will be defined, and acknowledging that this can be a complex 
combination of total number of treatment sessions over the study duration, number of treatment 
sessions per day, week or month, length of treatment sessions, intensity of treatment (possibly 
measured in a range of ways such as number of repetitions, or a measure of exertion). Where a 
comparison or control (C) intervention is defined it is important to consider that within some stroke 
research studies a control group which receives no active treatment may be unlikely (perhaps for 
ethical reasons), and consequently an active intervention may be compared to a variety of 
alternative interventions.  These could include “standard care” (which would need to be defined 
fully for the purposes of the review) or another active intervention, or the same active intervention 
delivered at a different dose or intensity.  It is important that the protocol states whether studies 
which deliver interventions in combination (e.g. constraint induced movement therapy plus 
electrical stimulation) will be eligible and, if so, how these studies with combined interventions will 
be brought together with studies of single interventions.   
Outcomes (O) that are of interest to the research question should be defined; these ought to be 
outcomes which are meaningful to patients and other key stakeholders, and it may be appropriate 
to consider the views of stroke survivors, carers and/or health professionals when determining what 
outcomes are most important (59).  Acceptable methods for measuring an outcome should be 
stated, including any objective measures (e.g. blood pressure, number of strokes, number of falls, 
walking speed) or subjective scales (e.g. Barthel Index, Fugl-Meyer Assessment, quality of life scales).  
To avoid the introduction of bias the outcome of greatest interest should be defined as the primary 
outcome, and additional outcomes as secondary outcomes.  The timing of the outcome of interest 
should be clearly defined, and consideration given to how measurements taken at different times in 
the research study, and at different times post stroke, will be included. 
Another key parameter to be defined is the types of study design which will be included in the 
systematic review.  For Cochrane intervention reviews this is often limited to randomised controlled 
trials, but other reviews may include other types of study (e.g. observational studies).  For example, 
considering the question relating to physical rehabilitation in Box 1, the question could be 
broadened to consider issues relating to stroke survivors’ views and experiences of rehabilitation 
therapies, resulting in the inclusion of qualitative research studies (e.g. studies  reporting results 
from interviews and / or discussions in focus groups). 
3.2. Find relevant research 
The protocol should include the full search strategy, which ought to be developed with appropriate 
expert advice or support from an information specialist, and description of electronic databases, and 
any other sources, which are to be searched.  There are a wide-range of health-related bibliographic 
databases, some covering broad areas of healthcare research (e.g. MEDLINE(60) and EMBASE(61)) 
while some focus on specific study designs (e.g. the Cochrane Database of Systematic Reviews(62)), 
more narrow specialist areas (e.g. PsychINFO for behavioural and social science research(63), PEDro 
for physiotherapy related trials, reviews and guidelines(64), REHABDATA for rehabilitation 
research(65)) or a particular language or geographical area of publication (e.g. Wangfangdata, a 
database of Chinese studies(66)).   In general, multiple electronic databases should be used, in an 
attempt to be comprehensive and avoid introduction of reporting bias(67).       
Consideration should be given to how the search results will be managed, including use of any 
bibliographic or data management software. For example, adequate records of the results of the 
search and application of eligibility criteria must be kept, in order to complete a detailed PRISMA 
flowchart (Figure 4).  The methods for identifying studies for inclusion should detail processes for 
screening of titles or abstracts in order to remove irrelevant reports, application of eligibility criteria 
to abstracts or full texts, and final decision making.  It should be clear which of these processes will 
be carried out by two independent reviewers, and if there are independent reviewers what the 
process will be if there is disagreement.  The use of two independent reviewers at key stages in the 
review process is considered an important approach in order to avoid one single reviewer 
introducing a biased (or flawed) interpretation of review criteria.  At the end of this stage of the 
review process the final list of included studies will have been identified. 
3.3. Collect data 
‘Data’ refers to any information within the included studies, including information relating to the 
characteristics of the study as well as to quantitative and/or qualitative results.  The protocol should 
define the data which will be extracted from each study, who will extract it and in what format.  
Methods to avoid the introduction of errors (e.g. entering wrong numerals into a spreadsheet; 
failure to identify required data from a study report) or bias should be considered, and may involve 
the use of two independent reviewers.   Information extracted relating to stroke populations could 
incorporate data associated with stroke diagnosis (e.g. type, severity of stroke; lesion site; date or 
time since stroke; measures of initial impairment or disability) and demographic variables (e.g. age, 
gender, socioeconomic status, level of education, handedness).  The TIDieR template (58) may be a 
useful tool for extraction of data relating to complex interventions, and could be incorporated into 
data extraction plans.  Data should also be systematically collected relating to the design and 
conduct of the research study, such as the method of randomisation and allocation concealment in 
the case of a randomised controlled trial.  The protocol should also state which specific statistical 
variables (e.g. mean, confidence intervals, standard deviation) will be extracted. 
3.4. Assess quality of included studies 
A key stage within a systematic review is the assessment of the methodological quality of the 
included studies.  This process involves critical appraisal and judgement relating to whether there 
were any potential risks of bias within the study.  A bias is a “systematic error, or deviation from the 
truth, in results or inferences” (68), and this can lead to findings which do not reflect the true result 
(69). Table 2 summarises common sources of bias, summarising methods which can be used to avoid 
or limit the introduction of bias, and giving examples of bias identified in studies included in our 
example review (35).  Within stroke research bias is a common risk when masking of study 
participants and investigators is not possible, as is the case when testing many non-pharmacological 
interventions. For example outcome assessors may inadvertently provide greater encouragement 
during the measurement of walking speed in the intervention group than in the control group 
(performance bias), or may record more positive outcomes for those in the treatment group  when 
using a subjective rating scale or questionnaire (detection bias). Bias can also result if dropouts (for 
example, due to death or subsequent stroke) occur more often in one group than the other (attrition 
bias), or if studies or outcomes are reported selectively, depending on the results (reporting bias). 
There are a large number of tools available to support critical appraisal of study quality (Table 1)(70).  
These tools can be ‘scales’ which score quality components and provide a summary score.  Despite 
the existence of a wide number of scales to assess quality (71), the use of scales is explicitly 
discouraged by Cochrane (68) as the validity and transparency of such summative scales can be 
questioned (72).   The Cochrane risk of bias tool is now recommended for use within all Cochrane 
reviews, and is widely used by non-Cochrane reviews of randomised controlled trials. Figure 5 shows 
how risk of bias can be presented, using our example review (35). 
The risk of reporting bias can be assessed using a funnel plot, which shows estimates of effect size 
from included studies against a measure of each study’s size or precision.  An asymmetrical funnel 
plot can indicate reporting bias, for example if a search strategy had failed to identify small 
unpublished studies which did not show statistically significant effects, while larger published studies 
with statistically significant effects were identified.  The presence of funnel plot asymmetry is often 
judged subjectively through visual inspection, but a number of statistical tests have been 
proposed(73). It is important to note that asymmetry within a funnel plot can be due to reasons 
other than reporting bias, for example poor methodological quality(73).  Funnel plots are not 
recommended if there are less than 10 studies in a meta-analysis(73), and in these cases the 
potential impact of reporting bias should be considered without statistical analysis. 
Assessment of quality requires adequate reporting of information in the individual study reports.  
The protocol should detail how absence of information (i.e. lack of reporting) will be incorporated 
into the assessment of risk of bias, and consider how to distinguish between a study for which risk of 
bias is unclear, and a study for which there is clear evidence of specific bias.  The protocol may also 
describe methods to attempt to seek missing information, such as contacting research authors or 
imputing alternative values. 
In addition to describing how risk of bias will be assessed, the protocol should also state how the risk 
of bias assessment will be used.  Some systematic reviews may exclude studies which are judged to 
be of poor methodological quality, or at high risk of bias, from subsequent synthesis. However a 
more comprehensive and transparent approach is arguably to maintain all included studies and 
perform sensitivity analyses to explore the impact of excluding studies which have been judged to be 
at high risk of bias. 
3.5. Synthesise evidence 
All systematic reviews should include a synthesis of the data that have been found.  Data synthesis 
can involve summarising results (quantitative and/or qualitative findings) in tables, or producing 
narrative summaries.   
Systematic reviews of quantitative data may include statistical pooling (meta-analysis).  Figure 6 
shows a typical Forest plot used in most reviews of quantitative data, using our example review (35).  
In this example, the data being combined comprise a number of continuous outcome scales and the 
statistical effect measure determined is the standardised mean difference;  if only one outcome 
scale was used a mean difference may be calculated and if outcome data are dichotomous the effect 
measure selected may be an odds or risk ratio, or risk difference.  Key components which ought to 
be specified at the protocol stage include; the comparisons (meta-analyses) which are planned, the 
types of data and outcome measures which will be combined, the statistical method for pooling data 
and effect measure which will be used, and how heterogeneity will be assessed and interpreted. For 
example, the choice of statistical method for pooling data will depend on whether the heterogeneity 
between effect estimates are most likely due to clinical or methodological diversity between studies 
(in which case a fixed-effect method should be used), or whether it is most likely due to random 
variation (in which case a random-effect method should be used)(74). The protocol should also 
specify which subgroup and sensitivity analysis are planned. Examples of subgroup analyses that 
were considered relevant and carried out within our example review (35), are given in Box 3. Where 
statistical pooling is not planned (for example within systematic reviews of observational studies) 
tables summarising results of individual studies can be useful. 
Systematic reviews including qualitative studies may adopt a number of different formal synthesis 
methods (22, 23, 75-77).  Readers are referred to appropriate texts relating to specific synthesis 
techniques; however, there is considerable confusion in the published literature in relation to the 
terminology used to describe methods of synthesising qualitative or mixed method studies (21, 78).     
Cochrane does not recommend a specific synthesis approach for inclusion of qualitative evidence, 
highlighting that evaluation of the robustness of different methods is lacking (79).  
3.6. Interpret findings 
A plan for summarising key findings is an essential part of a systematic review.  This is often in the 
form of a table that summarises the key findings and the overall quality of the data, and it is good 
practice to decide what will go in this at the protocol stage (80).   The GRADE approach is being 
widely used within systematic reviews (81, 82), but other approaches are available (e.g. Weight of 
Evidence framework (69, 83)).  Table 3 shows a summary of findings table from our example review, 
using the GRADE approach. 
4. COMPLETE THE SYSTEMATIC REVIEW 
Following peer review and publication of the systematic review protocol, the review can be carried 
out, informed by the methods described in the protocol. Ideally there will not be any differences 
between the protocol and review, however if there are any deviations from protocol then these 
should be clearly documented, justified and reported within the final systematic review (49). 
A discussion within a completed systematic review should address a number of key points, including 
the quality and completeness of the data.  Any potential biases in the review process and any 
deviations from protocol should be discussed, as should any agreements or disagreements between 
the review findings and other relevant reviews, guidelines or policies.   The generalisability of the 
evidence to the original research question, and the implications of the review findings to clinical 
practice should be considered. However systematic reviews ought to avoid giving specific 
recommendations for clinical practice, since local circumstances, such as status of the health care 
system, costs of the intervention, and patients’ preferences must always be considered when 
making clinical decisions based on systematic review evidence.  Involvement of key stakeholders, 
including patients, carers and health professionals, may be beneficial at this stage, helping to 
interpret findings in a way that is meaningful to the users of the review (84-86).  Often a systematic 
review will highlight gaps in the evidence, or in the quality of the evidence, in which case specific 
implications for research should be derived.  This should move beyond a statement that “more 
research is needed” discussing the need for different types of study designs and proposing research 
questions which need to be addressed.     
5. AFTER REVIEW COMPLETION: PUBLICATION, DISSEMINATION AND UP-DATING 
After the systematic review has been reviewed and approved it should be made freely available 
through publication in a journal, electronic repository or other resource.  The publication should 
highlight any sources of funding for the review, and any competing interests between the review 
authors, funders, or other related organisations in the review production.  Systematic review 
authors should consider strategies for effective dissemination (87), and involvement of patients and 
the public seems to be important for successful implementation of research findings (26, 85, 86). 
The need for further work to highlight effective strategies for  implementation in the field of stroke 
care has been highlighted (88, 89). 
Ideally systematic reviews will be updated regularly in order to incorporate new studies, although 
decisions to update have to take many factors into account, including the importance of the topic, 
whether there is new evidence and the likelihood of this changing the conclusions of the review (90).  
Regular updating a systematic review is generally recommended and is a more efficient use of 
resources than embarking on a new review addressing the same question (90). 
 
6. CONCLUSIONS 
Systematic reviews in stroke are necessary to ensure that healthcare and research decisions are 
informed by the best possible, up-to-date research evidence, and that patients are provided with the 
best possible care.  A protocol is an essential part of all systematic reviews, ensuring rigorous, 
transparent methods.  Key stages in systematic reviews include the formulation of the research 
question, the identification of relevant research, data extraction, assessment of risk of bias, data 
synthesis, summary and interpretation of the findings. The review process should include strategies 
for dissemination.  Updating a systematic review after completion is important to ensure that the 
conclusions remain valid.  
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BOX 1: What is the research question? 
Background and question:  My patient has recently had a stroke, and can only walk with assistance. 
Many physiotherapists have a preference for a specific approach to rehabilitation (91, 92). These 
approaches include the Bobath approach (93, 94) and the motor learning approach (95).  What 
specific physiotherapy approach should I use in order to best improve the walking of my patient? 
Forming the PICO question: 
 Patient: Patients with acute stroke (less than 6 weeks) with reduced mobility 
 Intervention: Any specific approach to physiotherapy  
 Control: No physiotherapy 
 Outcome: Independence in activities of daily living; ability to walk independently 
PICO question:  In patients with a recent acute stroke (less than 6 weeks) with reduced mobility, is 
any specific physiotherapy approach method more beneficial than no physiotherapy at improving 

















Box 2: Should the review be broad or narrow? 
PICO question:  In patients with a recent acute stroke (less than 6 weeks) with reduced mobility, is 
any specific physiotherapy approach more beneficial than no physiotherapy at improving 
independence in activities of daily living and gait speed? 
Arguments in favour of a broad review:   
 Limiting the review to patients who had a stroke during the last 6 weeks will arguably result 
in a fairly “narrow” review, and potentially large volumes of evidence arising from other 
patients would be excluded.  A broader review would result in a review of a greater volume 
of evidence.  
 Assessing the effects of different physiotherapy approaches (not only the Bobath approach) 
will be clinically relevant to clinicians, who have to consider all available approaches when 
reaching a treatment decision. Limiting the review to only one specific approach (e.g. the 
Bobath approach) does not answer the clinical question relating to the relative effects of 
different approaches. 
 Considering control groups other than just a “no physiotherapy” control group will reflect 
the choice faced by many clinicians, who have to choose between two or more different 
approaches, rather than between one approach or no physiotherapy. 
 A broader review will have more data from additional studies, making it possible to perform 
meaningful subgroup analyses. 
Example of a broader review question: In patients with stroke with reduced mobility, is any specific 
approach to physiotherapy more beneficial than no physiotherapy or any other physiotherapy 
approach at improving independence in activities of daily living and gait speed? 
Arguments in favour of a narrow review:  
 The broad review would be more work (more articles to screen, more data to extract, more 
analyses to be done, more results to discuss). 
 There would be a need to consider the generalisability of results arising from this broad 
population to the sub-population of primary interest for this review (patients with stroke 
during the last 6 weeks).   
 A review focussed on just one physiotherapy approach (e.g. the Bobath approach) will be 
more concise and of greater interest for readers interested in this specific approach. 
Example of a more narrow review question: In patients with a recent acute stroke (less than 6 
weeks) with reduced mobility, is the Bobath approach more beneficial than the motor learning 





Box 3: What subgroup analyses are relevant? 
PICO question:  In patients with a recent acute stroke (less than 6 weeks) with reduced mobility is 
any specific physiotherapy approach more beneficial than no physiotherapy at improving 
independence in activities of daily living and gait speed? 
Relevant subgroup analyses to consider:  
 Effects of therapy given at different times after stroke (<1 week, 1-3 weeks, or 3-6 weeks) 
 Effects of therapy in different parts of the world (Europe, Australasia, America, Asia) 
 Effects of therapy at different doses/intensities (> 45 minutes/day,  30-45 minutes/day, 15-
30 minutes/day, <5 sessions/week, <2 sessions/week) 
 Effects of therapy delivered by different professions (physiotherapist, nurse, assistant 
therapist, carer/family member) 
 Effect of different specific therapy approaches (e.g. Bobath approach, motor learning 
approach, orthopaedic methods) 
 
 
TABLE 1: Types of systematic reviews, frameworks for review questions, and resources to support protocol development, quality assessment of studies 







Published examples from the field of 
stroke 
Framework  for systematic 
review questions 
Resources for protocol 
development 















What is the safety and effectiveness of 
thrombolytic therapy for the 
treatment of acute ischaemic stroke? 
(96)  
What is the effect of stroke unit care, 
as compared to alternative forms of 
care for people following a stroke? 
(97) 
Does fitness training after stroke 
reduce death, dependence and 
disability? (98) 
 




Outcome, Study type 
PICOT: Population, 
Intervention, Comparison, 


















reviews (MECIR) (101) 
Cochrane risk of bias 
tool (68) 
JBI Critical appraisal 
tools (102) 
 
Preferred Reporting Items 




Expectations of Cochrane 
Intervention Reviews 
(MECIR)(101) 











What is the accuracy of MRI for the 
detection of acute haemorrhagic 
lesions within 12 hours of stroke 
symptoms? (103) 
What is the accuracy of cognitive 
diagnosis of multidomain, cognitive 
impairment/dementia in stroke 
survivors? (104) 
PICOT: Population, Index test, 
Comparator, Outcome, Target 
Condition 
PPIRT: Population, Prior Tests, 
Index Tests, Reference 
Standard, Target Condition 
Cochrane Handbook 










checklist (107)  
Centre for Evidence 
Based Medicine 
(CEBM) Diagnostic 
PRISMA-DTA: Checklist for 
reporting of diagnostic 
test accuracy systematic 






JBI Critical appraisal 
tools (102)  










What is the worldwide incidence of 
stroke? (110) 
What is the prevalence of pre-stroke 
dementia and the prevalence and 
incidence of post-stroke dementia and 
their associated risk factors? (111) 
What are the predictors of upper limb 
recovery following stroke? (112) 
PEO: Population, Exposure, 
Outcomes  
PCO: Population, Context, 
Outcome  











JBI Critical appraisal 
tools (102)  
Meta-analysis of 
observational studies in 
epidemiology (MOOSE) 
(114) 
What is the 










What is the validity and reliability of 
the Modified Rankin Scale? (115) 
What are the psychometric properties 
of outcome measures used in stroke 
self-management interventions?  (116) 
 De Vet 2011. Chapter 




Standards for the 











What are the 
views or 
experiences of 





What are stroke survivors’ experiences 
of rehabilitation? (120) 
What are carers’ experiences of caring 
for stroke survivors? (121) 
 
SPIDER: Sample, Phenomena of 
Interest, Design, Evaluation, 
Research type (122)  
SPICE: Setting, Perspective, 
Intervention, Comparison, 
Evaluation (123)  
ECLIPS: Expectations, Client 
Group, Location, Impact, 
Professionals Involved, Service 
(124) 
Cochrane Handbook 
Chapter 20 (Qualitative 
research and Cochrane 
reviews)(79) 





JBI Critical appraisal 
tools (102) 
 
Enhancing transparency in 
reporting the synthesis of 
qualitative research: 
ENTREQ (125)  
Realist And Meta-
narrative Evidence 




TABLE 2: Common sources of bias in stroke research 
Common sources of 
bias 
Description of bias (68) Methods to avoid introduction of bias Examples from review of physical rehabilitation 
approaches (35) 
Selection bias The groups of participants who are 
being compared have differences 
at baseline, due to the way that 
participants have been allocated to 
groups. 
Randomisation (allocation of participants to groups 
based on a random process, or sequence, with the 
order of allocation concealed from all people involved 
in the study) 
Zhu 2006* allocated participants to groups  “according to 
time of hospital admission”.  This method introduced a 
risk of selection bias as the characteristics of participants 
could vary according to time, and the researchers could 
potentially influence the allocation of a participant to a 
specific treatment group. 
Performance bias The groups of participants receive 
differences in care, other than 
differences in the intervention 
which is being tested. 
Masking (blinding) of participants and personnel 
(concealment) to the study treatment being delivered 
Dean 2000, Chan 2006 and Gelber 1995* did not use 
masking of person delivering the intervention, who could 
therefore be more enthusiastic and encouraging towards 
patients in the intervention group than the control group. 
Detection bias The way outcomes are measured in 
the groups of participants differs.  
Masking (blinding) of outcome assessor to the study 
treatment being delivered 
Salbach 2004* un-masked outcome assessors, introducing 
a high risk of detection bias. 
Attrition bias There are differences in retention / 
withdrawals between the groups of 
participants. 
Complete data collection in both groups 
The reasons for missing data must be reported for 
each treatment group, so that any differences 
between groups can be explored.    




bias, and selective 
outcome reporting) 
There are systematic differences 
between reported and unreported 
findings. 
Comprehensive searching for all eligible studies 
(regardless of publication status) can help avoid 
publication bias. 
Pre-specification of outcome measures within a 
published protocol can help avoid selective outcome 
reporting. 
Statistical methods can be used to aid detection of 
reporting biases (funnel plots and sensitivity analyses). 
Trials published in non-English language and in Chinese 
journals may not all have been identified (35). 
*For references see Pollock 2014 (35)
Table 3: Summary of findings table from example review 
PICO question:  In patients with a recent acute stroke (less than 6 weeks) with reduced mobility is any specific 
physiotherapy method more beneficial than no physiotherapy at improving independence in activities of daily living 







No. of participants 
(studies) 





in ADL scales 






Quality of evidence downgraded as there was 
substantial statistical heterogeneity in results 









Quality of evidence downgraded twice as dose 
of physiotherapy varied substantially between 
studies, and 1/3 studies were carried out in 
China (and a significant subgroup effect 
relating to geographical location of the study 
was identified) 
This table is adapted from the summary of findings table within our example review (35), for the purpose of 
this article.  
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